import { createFileRoute, Link } from "@tanstack/react-router";
import { ArrowLeft, CheckCircle2, FileText, Globe2, ShieldCheck } from "lucide-react";
import { CTABand } from "@/components/site/Bits";

const imgArticle = "/assets/brain/industry_ivd_1786310578306.png";

export const Route = createFileRoute("/insights/ivdr-class-d-verification-notified-bodies")({
  head: () => ({
    meta: [
      { name: "robots", content: "noindex, follow" },
      { title: "EU IVDR Class D Verification Guide | NKB Regovanta" },
      {
        name: "description",
        content: "The rigorous regulatory verification route for high-risk infectious disease and blood group diagnostics under Regulation (EU) 2017/746.",
      },
      { property: "og:title", content: "EU IVDR Class D Verification Guide | NKB Regovanta" },
      {
        property: "og:description",
        content: "The rigorous regulatory verification route for high-risk infectious disease and blood group diagnostics under Regulation (EU) 2017/746.",
      },
      { property: "og:url", content: "https://www.nkbregovanta.com/insights/ivdr-class-d-verification-notified-bodies" },
      { property: "og:type", content: "article" },
      { property: "og:image", content: "https://www.nkbregovanta.com/assets/brain/insight_eu_mdr_1786440985783.png" },
      { name: "twitter:card", content: "summary_large_image" },
      { name: "twitter:title", content: "EU IVDR Class D Verification Guide | NKB Regovanta" },
      { name: "twitter:description", content: "The rigorous regulatory verification route for high-risk infectious disease and blood group diagnostics under Regulation (EU) 2017/746." },
      { name: "twitter:image", content: "https://www.nkbregovanta.com/assets/brain/insight_eu_mdr_1786440985783.png" },
    ],
    links: [
      { rel: "canonical", href: "https://www.nkbregovanta.com/insights/ivdr-class-d-verification-notified-bodies" },
    ],
  }),
  component: ArticlePage,
});

function ArticlePage() {
  return (
    <>
      <script
        type="application/ld+json"
        dangerouslySetInnerHTML={{
          __html: JSON.stringify({
            "@context": "https://schema.org",
            "@type": "BlogPosting",
            "headline": "EU IVDR Class D Verification: Overcoming Reference Laboratories and Notified Body Hurdles",
            "description": "The rigorous regulatory verification route for high-risk infectious disease and blood group diagnostics under Regulation (EU) 2017/746.",
            "image": "https://www.nkbregovanta.com/assets/brain/insight_eu_mdr_1786440985783.png",
            "author": {
              "@type": "Organization",
              "name": "NKB Regovanta Solutions Pvt. Ltd.",
              "url": "https://www.nkbregovanta.com"
            },
            "publisher": {
              "@type": "Organization",
              "name": "NKB Regovanta Solutions Pvt. Ltd.",
              "logo": {
                "@type": "ImageObject",
                "url": "https://www.nkbregovanta.com/favicon.png"
              }
            },
            "datePublished": "2026-09-02",
            "mainEntityOfPage": "https://www.nkbregovanta.com/insights/ivdr-class-d-verification-notified-bodies"
          })
        }}
      />

      <article className="bg-white py-16 lg:py-24">
        <div className="mx-auto max-w-4xl px-4 sm:px-6 lg:px-8">
          
          <Link to="/insights" className="inline-flex items-center gap-2 text-sm font-semibold text-navy/70 hover:text-navy transition-colors mb-8">
            <ArrowLeft className="h-4 w-4" /> Back to Insights
          </Link>

          <div className="flex items-center gap-3 mb-6">
            <span className="text-[11px] font-bold uppercase tracking-widest text-[#0b3a96] bg-blue-50 px-3 py-1 rounded-full border border-blue-100">
              EU IVDR & DIAGNOSTICS
            </span>
            <span className="text-navy/30 text-sm">•</span>
            <span className="text-sm font-medium text-navy/60">2026-09-02</span>
          </div>

          <h1 className="text-3xl sm:text-4xl lg:text-5xl font-extrabold text-navy leading-tight mb-6">
            EU IVDR Class D Verification: Overcoming Reference Laboratories and Notified Body Hurdles
          </h1>

          <p className="text-lg sm:text-xl text-blue-900/80 font-medium leading-relaxed mb-10 pb-6 border-b border-gray-100">
            The rigorous regulatory verification route for high-risk infectious disease and blood group diagnostics under Regulation (EU) 2017/746.
          </p>

          <img 
            src={imgArticle} 
            alt="EU IVDR Class D Verification: Overcoming Reference Laboratories and Notified Body Hurdles" 
            className="w-full h-[380px] sm:h-[420px] object-cover rounded-xl mb-12 shadow-md border border-gray-100" 
          />

          <div className="prose prose-lg max-w-none text-navy/80 space-y-6 leading-relaxed">
<h2 className="text-2xl sm:text-3xl font-bold text-navy mt-12 mb-6 tracking-tight">IVDR Verification of Class D IVDs</h2>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">This content has guidance for establishing the activities of Notified Bodies for the verification process of class D IVD devices. According to the law on in vitro diagnostic Medical Devices (IVDR), Regulation (European) 2017/746, class D devices need to demonstrate their conformity assessment via the involvement of a notified body. In those terms, manufacturers of class D IVDs should forward to notified bodies a report of tests performed on each batch of devices and make available samples or batches of devices to the notified body. The notified body involved in the conformity assessment of class D IVDs should request one of the European reference laboratories (EURLs), if designated via the European commission, to carry out batch testing on those devices. Only upon verification of conformity, the manufacturer can proceed to place class D IVDs on the market.</p>

<ul className="my-6 space-y-2 list-disc list-inside text-navy/80 bg-slate-50/60 p-5 rounded-xl border border-slate-200/60">
  <li className="leading-relaxed"><span className="text-navy font-medium">Make your transition to IVDR easy with one stop solution at NKB Regovanta.</span></li>
  <li className="leading-relaxed"><span className="text-navy font-medium">We help you in the process of making a defined and comprehensive technical file with all product details required for CE Mark Medical Device.</span></li>
</ul>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">Regulatory Excellence for Global Medical Device Markets</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">IVDR – Verification of class D IVDs by notified bodies</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">The main points provided by using the guidance include Notified Body process, contractual arrangements, and overall performance of checking out, indexed right here below:</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">Notified Body Procedures</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">Appointed by means of the manufacturer, the Notified Body performs conformity assessment activities of manufactured class D devices. The agreement between the notified body and the manufacturer should include all necessary preparations related to the performance of the exams, inclusive of a test plan, the transportation of the samples, and all records related to the batches, e.g., batch release quality control results, and conclusions of the verification of manufactured batches. Furthermore, the manufacturer commits to inform the Notified Body about any changes in the devices that affect the verification of the batches as well as to communicate any relevant scientific, technical, or medical information that comes to his knowledge.</p>

<ul className="my-6 space-y-2 list-disc list-inside text-navy/80 bg-slate-50/60 p-5 rounded-xl border border-slate-200/60">
  <li className="leading-relaxed"><span className="text-navy font-medium">NKB Regovanta Medical device consulting Company. We’ll also provide assistance in your process of making a technical file and review it at every step for compliance, to know more details on this you can Contact Us Or WhatApps.</span></li>
</ul>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">Moreover, the Notified Body has to establish documented processes for:</p>

<ul className="my-6 space-y-2 list-disc list-inside text-navy/80 bg-slate-50/60 p-5 rounded-xl border border-slate-200/60">
  <li className="leading-relaxed"><span className="text-navy font-medium">The verification processes</span></li>
  <li className="leading-relaxed"><span className="text-navy font-medium">The establishment of a test plan including all relevant and critical parameters which have to be examined for the device</span></li>
  <li className="leading-relaxed"><span className="text-navy font-medium">The arrangements with the manufacturer specifying where and when the tests will be performed</span></li>
</ul>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">EURL Testing: Arrangements and Procedure</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">Assuming that the device desires to undergo further checks performed by an EURL, the notified body needs to make certain arrangements for such testing. Similarly, a written contract between them should define all necessary processes for the trying out. This includes, for example, the check plan, the transportation of the samples, batch information, and predicted time-frame for trying out (commonly 30 days). Moreover, the notified body commits to tell the EURL approximately any applicable scientific, technical, or clinical observations that come to his attention as well as to speak about all important facts from the conformity check.</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">Frequency of EURL Trying Out</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">The notified body should send samples of batches to the EURL, specifying the products made to be had to the EURL and the frequency of checking out. The frequency of testing ought to be based on the frequency of device failure and the relative risk/impact by the intended use. Thus, batches that must be tested more frequently are batches of devices with higher failure, devices with presence of or exposure to transmissible agents, and batches of blood grouping devices. The notified body can, together with the EURL, reduce the frequency of testing upon a demonstrated history of appropriate overall performance.</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">Number of Batches to Test</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">For first-line assays and devices intended for diagnosis, every single batch must be tested. For other devices, the notified body determines the number of batches to be tested. To do so, the notified body considers the batch-testing regime defined by the manufacturer, the scientific opinion of the EURL, and possibly, the additional opinions of further experts.</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">Reference link – IVDR: Verification of class D IVDs by notified bodies · MDlaw – Information platform on European medical device regulations</p>

<h2 className="text-2xl sm:text-3xl font-bold text-navy mt-12 mb-6 tracking-tight">Categories</h2>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">CDSCO Category</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">Medical device Manufacturing</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">News/Updates</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">QMS</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">Regulatory</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">Turnkey Project Management</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">US FDA</p>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">Subscribe Newsletter</p>

<h2 className="text-2xl sm:text-3xl font-bold text-navy mt-12 mb-6 tracking-tight">Recent Posts</h2>

<p className="text-base sm:text-lg leading-relaxed text-navy/80 my-5">Predetermined Change Control Plan (PCCP) for SaMD: FDA Requirements</p>
          </div>

          <div className="mt-16 p-8 bg-gradient-to-br from-blue-50/60 to-slate-50 border border-blue-100 rounded-2xl">
            <h3 className="text-2xl font-bold text-navy mb-4">How NKB Regovanta Can Support Your Programme</h3>
            <p className="text-navy/80 leading-relaxed mb-6">
              Our multidisciplinary team of regulatory affairs strategists, former auditors, and quality system engineers partners with medical technology innovators worldwide. We bridge complex regulatory standards with practical, commercial market-access pathways.
            </p>
            <div className="grid sm:grid-cols-2 gap-4">
              <div className="flex items-center gap-3 p-3 bg-white rounded-lg border border-blue-100/60">
                <CheckCircle2 className="h-5 w-5 text-accent shrink-0" />
                <span className="text-sm font-semibold text-navy">Global Regulatory Strategy &amp; Submissions</span>
              </div>
              <div className="flex items-center gap-3 p-3 bg-white rounded-lg border border-blue-100/60">
                <ShieldCheck className="h-5 w-5 text-accent shrink-0" />
                <span className="text-sm font-semibold text-navy">Technical Documentation &amp; GSPR Files</span>
              </div>
              <div className="flex items-center gap-3 p-3 bg-white rounded-lg border border-blue-100/60">
                <FileText className="h-5 w-5 text-accent shrink-0" />
                <span className="text-sm font-semibold text-navy">ISO 13485 &amp; FDA QMSR Implementation</span>
              </div>
              <div className="flex items-center gap-3 p-3 bg-white rounded-lg border border-blue-100/60">
                <Globe2 className="h-5 w-5 text-accent shrink-0" />
                <span className="text-sm font-semibold text-navy">Market Authorization &amp; Authorized Representation</span>
              </div>
            </div>
          </div>
        </div>
      </article>

      <CTABand 
        title="Ready to navigate your medical device regulatory pathway?" 
        description="Speak directly with NKB Regovanta's senior regulatory consultants for clear, practical guidance." 
        action="Schedule a Consultation" 
      />
    </>
  );
}
